Key Developments: Cutera Inc (CUTR.O)

CUTR.O on Nasdaq

9.61USD
24 May 2013
Price Change (% chg)

$0.13 (+1.37%)
Prev Close
$9.48
Open
$9.43
Day's High
$9.73
Day's Low
$9.33
Volume
50,002
Avg. Vol
126,954
52-wk High
$14.14
52-wk Low
$6.33

Search Stocks

Latest Key Developments (Source: Significant Developments)

Cutera, Inc. Sees Q2 2012 Charge Guidance-Conference Call
Thursday, 10 May 2012 04:00pm EDT 

Cutera, Inc. announced that in the second quarter of 2012, it expects a $360,000 charge associated with stock compensation expenses for independent Board members.  Full Article

Cutera, Inc. Closes Acquisition Of IRIDEX Aesthetic Business Unit
Friday, 3 Feb 2012 06:30am EST 

Cutera, Inc. announced that it has closed the previously announced asset purchase of IRIDEX' global aesthetic business for $5.1 million in cash.  Full Article

Cutera, Inc. And IRIDEX Corporation Announces Acquisition Of IRIDEX' Aesthetic Business Unit
Tuesday, 3 Jan 2012 06:00am EST 

Cutera, Inc. and IRIDEX Corporation announced that the companies have entered into a binding agreement for Cutera to purchase certain assets of IRIDEX' global aesthetic business for approximately $5.1 million. The transaction is expected to close in early 2012 and has been approved by both Boards of Directors. Cutera expects to fund the acquisition through its existing cash resources. IRIDEX will continue supporting its customers worldwide until Cutera assumes this responsibility after closing. The parties have also entered into an agreement for IRIDEX to supply Cutera with transitional product and service support.  Full Article

The Law Firm of Levi & Korsinsky, LLP Announces Investigation of Cutera, Inc.
Monday, 25 Jul 2011 07:18pm EDT 

Levi & Korsinsky, LLP announced that it is investigating Cutera, Inc., and its Board of Directors, in connection with the Company’s 2010 compensation for its CEO and other executives. At the Company’s recent annual shareholder meeting held June 14, 2011, shareholders voted “no” on Cutera’s say on pay provision. The investigation concerns whether certain senior officers and executives of Cutera were awarded salaries, bonuses, and/or other forms of compensation that were excessive or unwarranted based on Cutera’s performance. Specifically, Cutera’s CEO received $1.15 million in 2010, up from $919,738 in 2009. Executive pay was increased despite the fact that shares have dropped from a high of $12.04 in April 2010 to a high of $9.94 in March of 2011.  Full Article

Cutera, Inc. Announces Health Canada Approval for GenesisPlus Laser System for Onychomycosis
Wednesday, 20 Jul 2011 05:44pm EDT 

Cutera, Inc. announced that Health Canada approval for its GenesisPlus laser system. Featuring a powerful Nd: YAG laser, GenesisPlus provides a fast, effective and drug-free treatment for onychomycosis (nail fungus), warts and scars.  Full Article

Search Stocks